VANESSA DARNELL: Open Payments
NPI 1679806137 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 24 payments from 13 companies in 2025. Trend: 2023 $277 · 2024 $982 · 2025 $593
Food & beverage: $494Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $173 |
| Astellas Pharma US Inc | 2 | $118 |
| Novo Nordisk Inc | 6 | $109 |
| Exact Sciences Corporation | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Ascendis Pharma Endocrinology Inc | 1 | $16 |
| Alkermes, Inc. | 1 | $16 |
Products named: VRAYLAR, Ozempic, The Cologuard Plus Collection Kit, QULIPTA, Wegovy, REXULTI, Kerendia, Veozah.
Industry payments across OR — which companies pay providers there.
